Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (RARE) Q1 2024 Earnings Report

1 Followers

MX:RARE Q1 2024 EPS Results

Actual EPS
-MXN 38.83
Consensus EPS
-MXN 33.42
Beat/Miss
Missed by -MXN 5.41
One Year Ago EPS
-MXN 44.57

MX:RARE Q1 2024 Revenue Results

Actual Revenue
MXN 2.08B
Expected Revenue
MXN 2.22B
Beat/Miss
Missed by -MXN 137.73M
YoY Revenue Growth
+8.30%

Earnings Announcement Details

Quarter
Q1 2024
Date
05/02/2024
Time
After Close
Conference Call
Thursday, May 2, 2024
MX:RARE Upcoming Earnings

Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q1 2024 Earnings Call Audio

MX:RARE Q1 2024 Earnings Call
0:00 / 0:00

Q1 2024 Earnings Slide Deck

Q1 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:RARE Earnings History

MX:RARE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)45.28--24.68――
Nov 03, 20262026 (Q3)-21.04-22.19-34.6235.91% (+12.43)
Aug 04, 20262026 (Q2)-23.76-17.22-22.3823.08% (+5.16)
May 05, 20262026 (Q1)-28.46-35.20-30.03-17.20% (-5.16)
Feb 12, 20262025 (Q4)-20.91-24.68-26.597.19% (+1.91)
Nov 04, 20252025 (Q3)-23.61-34.62-26.78-29.29% (-7.84)
Aug 05, 20252025 (Q2)-24.81-22.38-29.0823.03% (+6.70)
May 06, 20252025 (Q1)-30.57-30.03-38.8322.66% (+8.80)
Feb 13, 20252024 (Q4)-25.02-26.59-29.088.55% (+2.49)
Nov 05, 20242024 (Q3)-28.39-26.78-42.6637.22% (+15.88)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed